4 medicines held by Amgen Technology (Ireland) Unlimited Company on the Irish market, from the HPRA register of authorised products.
| Medicine | Active substance | Licence holder | Status |
|---|---|---|---|
| BEKEMV 300 mg Concentrate for solution for infusion EU/1/23/1727/001 |
Eculizumab | Amgen Technology (Ireland) Unlimited Company | — |
| MVASI 25 mg/mL Concentrate for solution for infusion EU/1/17/1246/001-002 |
Bevacizumab | Amgen Technology (Ireland) Unlimited Company | — |
| PAVBLU 40 mg/mL solution for injection in a vial EU/1/25/1909/002 |
Aflibercept | Amgen Technology (Ireland) Unlimited Company | — |
| PAVBLU 40 mg/mL solution for injection in pre-filled syringe EU/1/25/1909/001 |
Aflibercept | Amgen Technology (Ireland) Unlimited Company | — |
Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 13 September 2026).
Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.